Pet Health

Cytopoint (Lokivetmab) for Dogs: Itch Relief & Side Effects

2 min read Updated Clinically reviewed • Standards
In this guide
Editorial policy
Health and Safety Boundary

This guide is general education for pet owners. If your pet has urgent symptoms, possible poisoning, injury, breathing trouble, collapse, severe pain, or sudden decline, contact a licensed veterinarian or local emergency service.

Editorial standard

How this guide was prepared

Edited for decisions NewsPet guides are structured around practical owner choices, tradeoffs, and safety boundaries.
Source policy Sources are listed when a guide relies on outside references.
Veterinary boundary This article does not diagnose or prescribe; urgent symptoms need veterinary care.
Corrections Readers can flag unclear, outdated, or inaccurate information through our contact page.

Cytopoint (Lokivetmab) for Dogs: Itch Relief & Side Effects

Clinical Classification & Indications

  • Drug Class: Caninized Monoclonal Antibody (mAb)
  • Approved Uses: Treatment of dogs against atopic and allergic dermatitis, targeting the cycle of chronic canine pruritus for 4 to 8 weeks per subcutaneous injection.

Mechanism of Action (Pharmacodynamics)

A targeted caninized biological monoclonal antibody that specifically binds to and neutralizes circulating Interleukin-31 (IL-31), preventing it from binding to peripheral nerve receptors and interrupting itch signal transmission.

Refrigerated single-dose vial of Cytopoint 20mg lokivetmab with sterile syringe and packaging highlighting IL-31 neutralization
Figure 1: Pharmaceutical exhibit of Cytopoint (lokivetmab) 20 mg single-dose vial and sterile syringe detailing targeted neutralization of canine Interleukin-31 (IL-31) pruritic cytokine.

Adverse Reactions & Side Effect Profile

Common / Expected Side Effects
Lethargy (most common in first 24-48 hours), transient injection site soreness, mild gastrointestinal upset (vomiting or diarrhea).

Emergency Red Flag Reactions
Acute hypersensitivity or anaphylaxis: facial swelling (angioedema), hives (urticaria), respiratory distress, pale gums, collapse within minutes to hours post-injection.

Veterinarian administering subcutaneous injection of Cytopoint into dorsal scruff of calm French Bulldog with allergic dermatitis
Figure 2: Clinical subcutaneous administration of lokivetmab in a veterinary dermatology suite for sustained 4 to 8 week biological itch cycle disruption in canine atopic dermatitis.

Clinical Contraindications & Interactions

  • Do Not Use In: Known hypersensitivity to lokivetmab. Because it is a protein eliminated via normal cellular catabolism, it is safe to use in dogs of any age and in dogs with concurrent renal or hepatic impairment.

Strict Rule S1 Veterinary Prescription Directive

VETERINARY DIRECTIVE: Cytopoint must be administered exclusively by a licensed veterinary professional via subcutaneous injection. It cannot be dispensed as an oral home medication. Minimum interval between doses is typically 4 weeks. Never administer human pharmaceutical products or adjust dosages without direct examination and bloodwork by a licensed Doctor of Veterinary Medicine (DVM).

Printable tools

Download the matching worksheet

Continue Your Care Plan

Recommended next steps for your pet

Your Saved Guides

No guides saved yet. Click "Save guide" on any article to keep it here for quick access.